Human Nutrition · Omega-3 & Specialty Lipids

Omega-3 & Specialty Lipid Premix Manufacturer — Microencapsulated, Oxidation-Stable

Microencapsulated fish oil, vegan algal DHA, and plant-based omega-3 premixes with multi-layer oxidation protection — so EPA and DHA potency declared on your label survives through shelf life without fishy odour or rancidity.

Microencapsulated omega-3 fish oil premix powder for supplement and functional food manufacturing — NutraX Biotech

70%+

EPA+DHA Concentrate Available

TOTOX

Oxidation Controlled

Vegan

Algal DHA Available

30+

Export Countries

Compliance

FSSAI Compliant

Regulatory approved

WHO GMP Certified

Certified manufacturing

NABL Accredited CoA

Purity & oxidation tested

What We Supply

Omega-3 Premixes That Stay Fresh Through Shelf Life

Omega-3 fatty acids are among the most oxidation-prone ingredients in human nutrition manufacturing. Fishy odour, rancidity, and EPA/DHA degradation are not quality issues — they are formulation engineering failures. Our omega-3 premix manufacturing addresses oxidation at the source through multi-layer microencapsulation, antioxidant protection systems, and validated packaging.

We work with marine (fish oil), algal (DHA), and plant-based (flaxseed ALA, chia) omega-3 sources, each microencapsulated with an oxygen-barrier matrix and co-formulated with natural antioxidants. EPA and DHA concentration is verified by GC-FID fatty acid profiling on every commercial batch, with TOTOX value (peroxide value + anisidine value) confirmation that oxidation status meets specification.

For infant formula, maternal nutrition, and clinical applications, we manufacture algal DHA premixes to the concentration, particle size, and purity standards required by FSSAI infant food regulations and Codex Alimentarius infant formula standards.

Regulatory & Quality Standards

FSSAI Infant Food Standards (Omega-3 DHA)

DHA concentration requirements and permitted sources for infant formula and follow-on formula in India.

Codex Alimentarius Standard for Infant Formula (CODEX STAN 72)

International DHA and ARA composition requirements for infant formula products.

EFSA Opinion on DHA/EPA Health Claims

EU scientific opinion underpinning authorised omega-3 cardiovascular, cognitive, and maternal health claims.

GOED Voluntary Monograph for Omega-3 Oils

Global Organisation for EPA and DHA purity and oxidation standards (TOTOX, PV, AV) for omega-3 ingredient quality.

FSSAI Nutraceuticals & Health Supplements Regulations

Permitted omega-3 sources and maximum levels for Indian supplement and functional food applications.

WHO GMP (Current)

Manufacturing quality standards including lipid handling, encapsulation process controls, and packaging validation.

Product Range

Omega-3 & Specialty Lipid Types We Manufacture

Microencapsulated Fish Oil Omega-3 Powder

Fish oil premixes at 18:12 (EPA:DHA natural TG), 33:22, and concentrated 50–70% EPA+DHA (EE or rTG forms) in microencapsulated dry powder with verified TOTOX value and GC-FID fatty acid profile CoA.

Applications

SupplementsFunctional FoodsBeverages

Algal DHA Premix (Vegan Omega-3)

Schizochytrium sp. algal DHA in microencapsulated powder — odour-minimised, with concentration options from 25% to 40% DHA. Suitable for infant formula, maternal supplements, and plant-based functional food applications.

Applications

Infant FormulaVegan SupplementsMaternal Nutrition

Plant-Based ALA Omega-3 Premixes

Microencapsulated flaxseed oil (53–57% ALA) and chia oil premixes for plant-based supplement and functional food fortification. Organic and non-GMO certified options available.

Applications

Plant-BasedFunctional FoodsSupplements

Phospholipid Omega-3 Complexes

Krill-derived phospholipid omega-3 (with choline) and marine phospholipid concentrates for cognitive health, sports, and premium supplement applications with superior absorption over standard triglyceride forms.

Applications

Cognitive HealthSports NutritionPremium Supplements

High-EPA Omega-3 Premixes

EPA-dominant omega-3 premixes (EPA:DHA ≥ 3:1) for cardiovascular health and mood support applications, aligned to EFSA and FDA health claim evidence bases for EPA-specific benefits.

Applications

Cardiovascular HealthClinical NutritionSupplements

Maternal & Infant DHA Premixes

Low-odour algal and fish oil DHA premixes at FSSAI and Codex-specified concentrations for infant formula, growing-up milk, and maternal supplement applications, with pharmaceutical-grade CoA documentation.

Applications

Life Stage NutritionInfant FormulaMaternal

Technical Capabilities

How We Manufacture Omega-3 & Specialty Lipid Premixes

Omega-3 premix quality is determined at four points: raw material selection, encapsulation process, antioxidant system design, and packaging. We engineer each step to ensure the EPA and DHA on your label is present — without off-flavour — at the end of shelf life.

GC-FID Fatty Acid Profile Verification

All commercial batches verified by gas chromatography-flame ionisation detection for EPA, DHA, and ALA content — confirming label claim fatty acid concentrations before dispatch.

TOTOX / PV / AV Oxidation Testing

Peroxide value (PV), anisidine value (AV), and TOTOX composite index measured on all lots. Raw material PV <5 meq/kg and TOTOX <10 required before encapsulation approval.

Multi-Layer Microencapsulation

Modified starch-protein wall systems with oxygen-barrier properties, nitrogen-flush emulsification, and controlled drying to lock EPA/DHA inside a protective matrix.

Natural Antioxidant Co-Formulation

Mixed tocopherols, rosemary extract, and ascorbyl palmitate antioxidant systems co-formulated inside the encapsulation matrix and on the particle surface for dual-layer oxidation protection.

Sensory Evaluation & Odour Masking Validation

Panel-tested sensory assessments of fishy/algal odour before commercial batch release. Masking technology selection and dose guided by sensory data, not assumption.

Packaging Validation & Shelf-Life Prediction

Nitrogen-flushed, moisture-barrier packaging validated by headspace oxygen measurement. Accelerated stability studies model TOTOX trajectory to predict shelf-life compliance.

Common Questions

Omega-3 & Specialty Lipid FAQs

Case Studies

Delivering results for our clients

Client Voices

What our clients say

Get started

Request an Omega-3 Premix Specification

Tell us your EPA/DHA target, matrix, shelf life, and market — we'll return a formulation proposal with encapsulation options and oxidation stability data.